DCM
Driehaus Capital Management’s Spyre Therapeutics SYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2M | Sell |
2,085,590
-631,722
| -23% | -$9.46M | 0.25% | 131 |
|
|
2025
Q1 | $43.8M | Sell |
2,717,312
-86,343
| -3% | -$1.39M | 0.42% | 71 |
|
|
2024
Q4 | $65.3M | Buy |
2,803,655
+2,116,575
| +308% | +$49.3M | 0.54% | 52 |
|
|
2024
Q3 | $20.2M | Hold |
687,080
| – | – | 0.17% | 168 |
|
|
2024
Q2 | $16.2M | Hold |
687,080
| – | – | 0.16% | 175 |
|
|
2024
Q1 | $26.1M | Sell |
687,080
-84,822
| -11% | -$3.22M | 0.26% | 113 |
|
|
2023
Q4 | $16.6M | Sell |
771,902
-28,951
| -4% | -$623K | 0.2% | 169 |
|
|
2023
Q3 | $9.81M | Sell |
800,853
-3,842,504
| -83% | -$47.1M | 0.13% | 211 |
|
|
2023
Q2 | $2.09M | Buy |
+4,643,357
| New | +$2.09M | 0.03% | 299 |
|
|
2021
Q2 | – | Sell |
-175,000
| Closed | -$1.39M | – | 514 |
|
|
2021
Q1 | $1.39M | Sell |
175,000
-241,266
| -58% | -$1.91M | 0.02% | 339 |
|
|
2020
Q4 | $3.28M | Sell |
416,266
-5,901
| -1% | -$46.4K | 0.05% | 272 |
|
|
2020
Q3 | $2.99M | Sell |
422,167
-7,522
| -2% | -$53.3K | 0.06% | 239 |
|
|
2020
Q2 | $3.98M | Buy |
+429,689
| New | +$3.98M | 0.1% | 214 |
|